Frequently asked questions
Why can’t we name this product and why are we calling this treatment ‘new human temporary filler’ ?
Australian TGA (Therapeutic Goods Administration) regulations have prevented the naming of this well known treatment as it is deemed to be direct advertising of a "doctor only" medically prescribed S4 medication. It is an extremely safe treatment that has been used in facial cosmetic medicine, providing it is administered by a qualified doctor who has been well trained in the correct technique.
Key benefits
Patients experience immediate, visible results. It is an easy and effective way to smooth lines, wrinkles, scars, and to define the lip border. An immediate, visible difference in the patient's appearance may be achieved in one treatment session.
What is a human-based temporary filler?
This has recently been approved for use in Australia. It has been available in the USA for a long time. Building on more than two decades of safe and effective use of the previous "bovine" form of this filler, these new human-based temporary fillers are new breakthroughs in facial rejuvenation.
- NEW human-based temporary filler purified from natural human dermal tissue
- No skin test required
- Immediate results in a single office visit
- Formulated with lidocaine to minimize patient discomfort
- Replenishes human-based temporary filler safely and effectively
- From the market leader in human-based temporary filler Replacement Therapy®
NEW human-based temporary filler are aesthetic applications of the same tissue-engineering technology that has been successfully used in the treatment of burns and other wounds for nearly a decade. They contain human-based temporary filler, which has been purified from dermal tissue grown under controlled laboratory conditions.
Is it safe and effective?
Treatment with " NEW human-based temporary fillers are a safe and effective way to aid in the correction of –
- facial wrinkles
- glabellar lines
- nasolabial folds
- vermilion borders
- distensible scars
- and other soft tissue deficiencies.
The NEW human-based temporary filler are isolated and purified from human dermal tissue grown under controlled laboratory conditions. The starting dermal fibroblasts are rigorously screened for known pathogens, and the resultant tissue undergoes a series of tests to ensure that it is free from contaminants. In addition, as the "NEW” human-based temporary filler is isolated from the tissue, it is subjected to additional viral inactivation for added safety.
What is it made of?
NEW human-based temporary filler implants are sterile devices composed of highly purified human-based gel that is dispersed in phosphate-buffered physiological saline containing 0.3% lidocaine. " NEW human-based temporary filler is a non-cross-linked formulation used in the treatment of superficial lines, whereas th ethicker " Gel" is cross-linked and is primarily used in the treatment of more pronounced wrinkles.
NEW human-based temporary filler 1™ - Purified human-based Gel, 35 mg/ml, dispersed in saline. It is indicated to treat fine lines, wrinkles and shallow scars. It is appropriate for thin-skinned areas. No skin test is required.
NEW human-based temporary filler 2 and 3 Gel™ - Purified human-based "Coll" Gel 35 mg/ml, cross-linked with glutaraldehyde dispersed in saline. It is indicated to treat deep lines furrows and scars. No skin test is required.
How long does it last?
Different people absorb these 3 different strength gels differently. The implant will remain longer in a relatively static area such as scars rather than an area like lips, which are constantly moving. Most people will get between of effective treatment 3 to 6 months before needing a top up. The thicker strength human-based temporary fillers, Types 2 and 3, will last longer.
What are the possible side effects?
The risk of infection is always present with any injection and it is possible to experience a reaction to the process itself, such as mild bruising or a slight blush at the injection site. This does not mean it is necessary to discontinue treatment. Previous facial herpes simplex at the site of injection may recur if provoked by the injection.
Though unlikely, it is possible for the needle to be accidentally placed through a blood vessel during injection, which could result in temporary discoloration of the treated area.
Occasionally, injected human-based temporary filler has been reported as visible in the skin, in the form of a small raised or white area at the treatment site, which may persist from a few weeks to several months. Some areas (such as compressed scars) resist precise placement of the material, resulting in a slight elevation beside the defect.
If you are using drugs that reduce coagulation, such as aspirin and non-steroidal anti-inflammatory drugs, you may, as with any injection, experience increased bruising or bleeding at injection sites.
Active inflammatory skin conditions (eruptions such as cysts, pimples, rashes or hives) or infections require that treatment be postponed, until the condition has been controlled.
The safety of treatment during pregnancy or in infants or children has not been established.
With more than 1 million people treated since 1976, this temporary filler has proven to be safe.
Systemic complaints have been reported in fewer than five per one thousand people treated and included flu-like symptoms (nausea, dizziness, headache, joint aches), rash, visual disturbances, anaphylactoid reactions (severe allergic reaction) involving difficulty in breathing, and various systemic diseases including immune-mediated diseases.
Since every patient's expectations and physical make-up are different and every physician's technique is unique, there have been cases reported where human-based temporary filler injections have not achieved the desired result.